<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Know Your Numbers ‚Äî STI Transmission Risk Calculator</title>
    <link rel="preconnect" href="https://fonts.googleapis.com">
    <link rel="preconnect" href="https://fonts.gstatic.com" crossorigin>
    <link href="https://fonts.googleapis.com/css2?family=JetBrains+Mono:wght@400;500;600&family=Outfit:wght@300;400;500;600;700&display=swap" rel="stylesheet">
    <link rel="stylesheet" href="styles.css">
    <script src="https://cdn.jsdelivr.net/npm/chart.js"></script>
    <script id="MathJax-script" async src="https://cdn.jsdelivr.net/npm/mathjax@3/es5/tex-mml-chtml.js"></script>
    <script src="sources.js"></script>
</head>
<body>
    <div class="grain-overlay"></div>
    
    <nav class="nav">
        <div class="nav-brand">
            <span class="nav-icon">üìä</span>
            <span class="nav-title">Know Your Numbers</span>
        </div>
        <button class="nav-toggle" aria-label="Toggle navigation menu" aria-expanded="false">
            <span class="nav-toggle-bar"></span>
            <span class="nav-toggle-bar"></span>
            <span class="nav-toggle-bar"></span>
        </button>
        <div class="nav-links">
            <a href="#mission">Why This Exists</a>
            <a href="#calculator">Calculator</a>
            <a href="#testing">Testing Guide</a>
            <a href="#stis">STI Data</a>
            <a href="#methodology">Methodology</a>
        </div>
    </nav>

    <header class="hero">
        <div class="hero-content">
            <h1 class="hero-title">
                <span class="hero-title-line">The numbers your</span>
                <span class="hero-title-line accent">doctor won't tell you.</span>
            </h1>
            <p class="hero-subtitle">
                Evidence-based STI transmission probabilities. Interactive risk calculators. 
                Complete transparency in methodology. Make informed decisions about your sexual health.
            </p>
            <div class="hero-cta">
                <a href="#calculator" class="btn btn-primary">Calculate Your Risk</a>
                <a href="#stis" class="btn btn-secondary">Browse STI Data</a>
            </div>
        </div>
        <div class="hero-visual">
            <div class="stat-preview">
                <div class="stat-card">
                    <span class="stat-number">8</span>
                    <span class="stat-label">STIs Covered</span>
                </div>
<div class="stat-card">
                                    <span class="stat-number">20</span>
                                    <span class="stat-label">Studies Cited</span>
                                </div>
                <div class="stat-card">
                    <span class="stat-number">‚àû</span>
                    <span class="stat-label">Scenarios</span>
                </div>
            </div>
        </div>
    </header>

    <section id="mission" class="section mission-section">
        <div class="container">
            <div class="section-header">
                <span class="section-tag">The Problem</span>
                <h2>Why I Built This</h2>
            </div>
            <div class="mission-content">
                <div class="mission-text">
                    <p class="lead">
                        I'm frustrated. Every time I ask a doctor about STI transmission probabilities, 
                        I get the same non-answers: "Use a condom and you'll be fine" or "Don't worry about it."
                    </p>
                    <p>
                        That's not good enough. If I have a partner with an STI, I want to know the <em>actual numbers</em>. 
                        What's my probability of transmission per encounter? How does that change with condom use? 
                        What if we're together for a year versus a month?
                    </p>
                    <p>
                        Doctors seem to operate on a culture of managed information ‚Äî deciding what you 
                        "need to know" rather than giving you the data to make your own informed decisions. 
                        With HPV, for example, the medical establishment has largely planned for it to spread 
                        through the population rather than helping individuals understand and manage their risk.
                    </p>
                    <p>
                        <strong>This site changes that.</strong> Every number here comes from peer-reviewed studies. 
                        Every calculation is transparent. You can see the equations, adjust the variables, 
                        and understand exactly how your risk is computed.
                    </p>
                    <p class="disclaimer">
                        <strong>Disclaimer:</strong> This is not medical advice. This is mathematical modeling 
                        based on published research. Consult healthcare providers for personal medical decisions.
                    </p>
                </div>
                <div class="mission-principles">
                    <h3>Our Principles</h3>
                    <ul class="principles-list">
                        <li>
                            <span class="principle-icon">üìö</span>
                            <div>
                                <strong>Cite Everything</strong>
                                <p>Every transmission rate links to its source study</p>
                            </div>
                        </li>
                        <li>
                            <span class="principle-icon">üî¢</span>
                            <div>
                                <strong>Show the Math</strong>
                                <p>All equations displayed in notation and code</p>
                            </div>
                        </li>
                        <li>
                            <span class="principle-icon">üéõÔ∏è</span>
                            <div>
                                <strong>Your Variables</strong>
                                <p>Customize calculations to your situation</p>
                            </div>
                        </li>
                        <li>
                            <span class="principle-icon">‚ö†Ô∏è</span>
                            <div>
                                <strong>Honest Uncertainty</strong>
                                <p>We show confidence intervals, not false precision</p>
                            </div>
                        </li>
                    </ul>
                </div>
            </div>
        </div>
    </section>

    <section id="calculator" class="section calculator-section">
        <div class="container">
            <div class="section-header">
                <span class="section-tag">Interactive Tool</span>
                <h2>Risk Calculator</h2>
                <p class="section-desc">
                    Select an STI, input your scenario, and see your cumulative risk over time.
                </p>
            </div>
            
            <div class="calculator-grid">
                <div class="calculator-inputs">
                    <div class="input-group">
                        <label for="sti-select">Select STI</label>
                        <select id="sti-select">
                            <option value="hiv">HIV</option>
                            <option value="hsv2">Herpes (HSV-2)</option>
                            <option value="hpv">HPV</option>
                            <option value="chlamydia" selected>Chlamydia</option>
                            <option value="gonorrhea">Gonorrhea</option>
                            <option value="syphilis">Syphilis</option>
                        </select>
                    </div>
                    
                    <div class="input-group">
                        <label for="direction-select">Transmission Direction</label>
                        <select id="direction-select">
                            <option value="mtf">Male ‚Üí Female (Vaginal)</option>
                            <option value="ftm">Female ‚Üí Male (Vaginal)</option>
                        </select>
                    </div>
                    
                    <div class="input-group">
                        <label for="frequency-input">
                            Sex frequency per week: <span id="frequency-value">2</span>
                        </label>
                        <input type="range" id="frequency-input" min="1" max="21" value="2" step="1">
                        <div class="range-labels">
                            <span>1√ó/week</span>
                            <span>Daily</span>
                            <span>3√ó/day</span>
                        </div>
                    </div>
                    
                    <div class="input-group">
                        <label for="duration-input">
                            Time period: <span id="duration-value">12</span> months
                        </label>
                        <input type="range" id="duration-input" min="1" max="60" value="12" step="1">
                        <div class="range-labels">
                            <span>1 month</span>
                            <span>5 years</span>
                        </div>
                    </div>

                    <div class="current-rate-display">
                        <div class="rate-section-title">Per-Act Transmission Rate</div>
                        <div class="rate-comparison">
                            <div class="rate-item">
                                <span class="rate-label">Without condom:</span>
                                <span class="rate-value" id="per-act-rate">--</span>
                            </div>
                            <div class="rate-item">
                                <span class="rate-label">With condom:</span>
                                <span class="rate-value-group">
                                    <span class="rate-reduction" id="rate-reduction"></span>
                                    <span class="rate-value" id="adjusted-rate">--</span>
                                </span>
                            </div>
                        </div>
                        </div>
                </div>
                
                <div class="calculator-output">
                    <div class="chart-container">
                        <canvas id="risk-chart"></canvas>
                    </div>
                    <div class="result-summary">
                        <div class="result-main">
                            <span class="result-label">Cumulative risk after <span id="result-duration">12</span> months:</span>
                            <span class="result-value" id="result-probability">--</span>
                        </div>
                        <div class="result-explanation">
                            <p id="result-explanation-text"></p>
                        </div>
                    </div>
                </div>
            </div>
        </div>
    </section>

    <section id="testing" class="section testing-section">
        <div class="container">
            <div class="section-header">
                <span class="section-tag">Take Action</span>
                <h2>Testing Guide</h2>
                <p class="section-desc">
                    Know when to test, what to ask for, and what a "standard panel" actually includes.
                </p>
            </div>

            <div class="testing-content">
                <div class="testing-block">
                    <h3>üïê Window Periods</h3>
                    <p class="testing-intro">
                        You can't test the day after exposure. Each STI has a <strong>window period</strong> ‚Äî 
                        the time between infection and when a test can detect it. Testing too early = false negative.
                    </p>
                    <table class="testing-table">
                        <thead>
                            <tr>
                                <th>STI</th>
                                <th>Window Period</th>
                                <th>Test Type</th>
                            </tr>
                        </thead>
                        <tbody>
                            <tr>
                                <td>HIV</td>
                                <td><span class="citable" data-source="hiv_window_period_cdc">18‚Äì45 days (lab); 18‚Äì90 days (rapid)<span class="cite-tooltip"><span class="cite-tooltip-source">CDC HIV Testing</span><span class="cite-tooltip-quote">"An antigen/antibody lab test using blood from a vein can usually detect HIV 18 to 45 days after exposure ... A rapid antigen/antibody test done with blood from a finger stick can usually detect HIV 18 to 90 days after exposure"</span><a href="https://www.cdc.gov/hiv/testing/index.html#:~:text=An%20antigen%2Fantibody%20lab%20test%20using%20blood%20from%20a%20vein%20can%20usually%20detect%20HIV%2018%20to%2045%20days%20after%20exposure&text=A%20rapid%20antigen%2Fantibody%20test%20done%20with%20blood%20from%20a%20finger%20stick%20can%20usually%20detect%20HIV%2018%20to%2090%20days%20after%20exposure" target="_blank" class="cite-tooltip-link">View Source ‚Üí</a></span></span></td>
                                <td>Blood</td>
                            </tr>
                            <tr>
                                <td>Chlamydia</td>
                                <td><span class="citable" data-source="chlamydia_gonorrhea_window_nhs">2 weeks<span class="cite-tooltip"><span class="cite-tooltip-source">NHS Sexual Health Oxfordshire</span><span class="cite-tooltip-quote">"We usually say to wait ... 2 weeks for chlamydia and gonorrhoea"</span><a href="https://www.sexualhealthoxfordshire.nhs.uk/sti/incubation-periods/#:~:text=We%20usually%20say%20to%20wait&text=2%20weeks%20for%20chlamydia%20and%20gonorrhoea" target="_blank" class="cite-tooltip-link">View Source ‚Üí</a></span></span></td>
                                <td>Urine or swab</td>
                            </tr>
                            <tr>
                                <td>Gonorrhea</td>
                                <td><span class="citable" data-source="chlamydia_gonorrhea_window_nhs">2 weeks<span class="cite-tooltip"><span class="cite-tooltip-source">NHS Sexual Health Oxfordshire</span><span class="cite-tooltip-quote">"We usually say to wait ... 2 weeks for chlamydia and gonorrhoea"</span><a href="https://www.sexualhealthoxfordshire.nhs.uk/sti/incubation-periods/#:~:text=We%20usually%20say%20to%20wait&text=2%20weeks%20for%20chlamydia%20and%20gonorrhoea" target="_blank" class="cite-tooltip-link">View Source ‚Üí</a></span></span></td>
                                <td>Urine or swab</td>
                            </tr>
                            <tr>
                                <td>Syphilis</td>
                                <td><span class="citable" data-source="syphilis_window_nhs">4 weeks<span class="cite-tooltip"><span class="cite-tooltip-source">NHS Sexual Health Oxfordshire</span><span class="cite-tooltip-quote">"We usually say to wait ... 4 weeks for syphilis and HIV (in some circumstance you also need a test at 3 months)"</span><a href="https://www.sexualhealthoxfordshire.nhs.uk/sti/incubation-periods/#:~:text=We%20usually%20say%20to%20wait&text=4%20weeks%20for%20syphilis%20and%20HIV%20(in%20some%20circumstance%20you%20also%20need%20a%20test%20at%203%20months)" target="_blank" class="cite-tooltip-link">View Source ‚Üí</a></span></span></td>
                                <td>Blood</td>
                            </tr>
                            <tr>
                                <td>Herpes (HSV)</td>
                                <td><span class="citable" data-source="hsv_window_cdc">Up to 16 weeks (antibody test)<span class="cite-tooltip"><span class="cite-tooltip-source">CDC Herpes Testing</span><span class="cite-tooltip-quote">"After exposure, it can take up to 16 weeks or more for current tests to detect infection"</span><a href="https://www.cdc.gov/herpes/testing/index.html#:~:text=After%20exposure%2C%20it%20can%20take%20up%20to%2016%20weeks%20or%20more%20for%20current%20tests%20to%20detect%20infection" target="_blank" class="cite-tooltip-link">View Source ‚Üí</a></span></span></td>
                                <td>Blood or swab active sore</td>
                            </tr>
                            <tr>
                                <td>HPV</td>
                                <td><span class="citable" data-source="hpv_testing_cdc">No routine test exists<span class="cite-tooltip"><span class="cite-tooltip-source">CDC About HPV</span><span class="cite-tooltip-quote">"There is no test to find out a person's 'HPV status.' ... There are HPV tests that can screen for cervical cancer. Healthcare providers only use these tests for screening women aged 30 years and older."</span><a href="https://www.cdc.gov/sti/about/about-genital-hpv-infection.html#:~:text=There%20is%20no%20test%20to%20find%20out%20a%20person%E2%80%99s%20%E2%80%9CHPV%20status.%E2%80%9D&text=There%20are%20HPV%20tests%20that%20can%20screen%20for%20cervical%20cancer.%20Healthcare%20providers%20only%20use%20these%20tests%20for%20screening%20women%20aged%2030%20years%20and%20older" target="_blank" class="cite-tooltip-link">View Source ‚Üí</a></span></span></td>
                                <td>Pap smear (women 30+ only)</td>
                            </tr>
                            <tr>
                                <td>Trichomoniasis</td>
                                <td><span class="citable" data-source="trich_ashm_testing">No defined window period<span class="cite-tooltip"><span class="cite-tooltip-source">ASHM Contact Tracing Guidelines</span><span class="cite-tooltip-quote">"Incubation period ... There is insufficient data to provide a definitive period"</span><span class="cite-tooltip-warning">‚ö†Ô∏è NAAT testing can detect shortly after infection, but no established window period exists.</span><a href="https://contacttracing.ashm.org.au/trichomoniasis/#:~:text=There%20is%20insufficient%20data%20to%20provide%20a%20definitive%20period" target="_blank" class="cite-tooltip-link">View Source ‚Üí</a></span></span></td>
                                <td>NAAT (urine or swab)</td>
                            </tr>
                            <tr>
                                <td>Hepatitis B</td>
                                <td><span class="citable-unverified" title="Source needs verification">~4 weeks average (range 1-9 weeks)<span class="cite-tooltip"><span class="cite-tooltip-source">CDC/Medical Sources</span><span class="cite-tooltip-quote">HBsAg can be detected as early as 1 week and as late as 9 weeks after exposure. Average detection occurs around 4 weeks.</span><span class="cite-tooltip-warning">‚ö†Ô∏è Source not yet verified in test suite.</span></span></span></td>
                                <td>Blood (HBsAg test)</td>
                            </tr>
                        </tbody>
                    </table>
                </div>

                <div class="testing-block">
                    <h3>‚ö†Ô∏è What's NOT in a Standard Panel</h3>
                    <p class="testing-intro">
                        When you "get tested for everything," you probably <strong>weren't tested for everything</strong>. 
                        Standard STI panels vary by provider, but these are commonly excluded:
                    </p>
                    <table class="testing-table not-included-table">
                        <thead>
                            <tr>
                                <th>STI</th>
                                <th>Why It's Usually Excluded</th>
                                <th>How to Get Tested</th>
                            </tr>
                        </thead>
                        <tbody>
                            <tr>
                                <td>Herpes (HSV-1 & HSV-2)</td>
                                <td>
                                    <span class="citable" data-source="hsv_no_routine_screening_cdc">CDC does not recommend routine testing for people without symptoms<span class="cite-tooltip"><span class="cite-tooltip-source">CDC Herpes Screening</span><span class="cite-tooltip-quote">"CDC does not recommend herpes testing for people without symptoms in most situations. This is because of the limits of a herpes blood test and the possibility of a wrong test result."</span><a href="https://www.cdc.gov/herpes/testing/index.html#:~:text=CDC%20does%20not%20recommend%20herpes%20testing%20for%20people%20without%20symptoms%20in%20most%20situations.%20This%20is%20because%20of%20the%20limits%20of%20a%20herpes%20blood%20test%20and%20the%20possibility%20of%20a%20wrong%20test%20result" target="_blank" class="cite-tooltip-link">View Source ‚Üí</a></span></span>
                                </td>
                                <td>Ask specifically; blood test or swab active sore</td>
                            </tr>
                            <tr>
                                <td>HPV</td>
                                <td>
                                    <span class="citable" data-source="hpv_testing_cdc">No general test exists to find "HPV status"<span class="cite-tooltip"><span class="cite-tooltip-source">CDC About HPV</span><span class="cite-tooltip-quote">"There is no test to find out a person's 'HPV status.' ... There are HPV tests that can screen for cervical cancer. Healthcare providers only use these tests for screening women aged 30 years and older."</span><a href="https://www.cdc.gov/sti/about/about-genital-hpv-infection.html#:~:text=There%20is%20no%20test%20to%20find%20out%20a%20person%E2%80%99s%20%E2%80%9CHPV%20status.%E2%80%9D&text=There%20are%20HPV%20tests%20that%20can%20screen%20for%20cervical%20cancer.%20Healthcare%20providers%20only%20use%20these%20tests%20for%20screening%20women%20aged%2030%20years%20and%20older" target="_blank" class="cite-tooltip-link">View Source ‚Üí</a></span></span>
                                </td>
                                <td>Cervical Pap smear (women 30+); visual inspection for warts</td>
                            </tr>
                            <tr>
                                <td>HIV</td>
                                <td>Some clinics require opt-in or separate consent</td>
                                <td>Request specifically; many clinics offer free/confidential testing</td>
                            </tr>
                            <tr>
                                <td>Trichomoniasis</td>
                                <td>
                                    <span class="citable" data-source="trich_cdc_prevalence">Not nationally reportable; no routine screening recommendations<span class="cite-tooltip"><span class="cite-tooltip-source">CDC STI Treatment Guidelines</span><span class="cite-tooltip-quote">"Because trichomoniasis is not a reportable disease, and no recommendations are available for general screening for T. vaginalis, the epidemiology of trichomoniasis has largely come from population-based and clinic-based surveillance studies."</span><a href="https://www.cdc.gov/std/treatment-guidelines/trichomoniasis.htm#:~:text=Because%20trichomoniasis%20is%20not%20a%20reportable%20disease%2C%20and%20no%20recommendations%20are%20available%20for%20general%20screening%20for%20T.%20vaginalis" target="_blank" class="cite-tooltip-link">View Source ‚Üí</a></span></span>
                                </td>
                                <td>Request NAAT test specifically (urine or swab)</td>
                            </tr>
                        </tbody>
                    </table>
                    <p class="testing-warning">
                        <strong>üí° Bottom line:</strong> Always ask your provider <em>"What exactly am I being tested for?"</em> 
                        Don't assume "full panel" means everything.
                    </p>
                </div>
            </div>
        </div>
    </section>

    <section id="stis" class="section stis-section">
        <div class="container">
            <div class="section-header">
                <span class="section-tag">The Data</span>
                <h2>STI Profiles</h2>
                <p class="section-desc">
                    Click any STI for detailed transmission data, risk factors, and sources.
                </p>
            </div>

            <div class="classification-legend">
                <p class="legend-intro">Each STI shows three key facts: how long it lasts, what happens without treatment, and what happens with treatment.</p>
                <div class="legend-grid">
                    <div class="legend-col">
                        <h4>Duration</h4>
                        <ul>
                            <li><strong>Curable</strong> ‚Äî Gone after treatment</li>
                            <li><strong>Usually Clears</strong> ‚Äî Body fights it off</li>
                            <li><strong>Chronic</strong> ‚Äî Lifelong</li>
                        </ul>
                    </div>
                    <div class="legend-col">
                        <h4>If Untreated</h4>
                        <ul>
                            <li>What happens if you ignore it</li>
                            <li>Ranges from mild to <strong>life-threatening</strong></li>
                        </ul>
                    </div>
                    <div class="legend-col">
                        <h4>With Treatment / Prevention</h4>
                        <ul>
                            <li>What happens when you take action</li>
                            <li>Usually <strong>much better</strong> than untreated</li>
                        </ul>
                    </div>
                </div>
            </div>
            
            <div class="sti-grid">
                <!-- HIV -->
                <article class="sti-card" id="sti-hiv">
                    <div class="sti-header">
                        <h3>HIV</h3>
                    </div>
                    <div class="sti-outlook">
                        <div class="outlook-item">
                            <span class="outlook-label">Duration</span>
                            <span class="outlook-value chronic">Chronic</span>
                        </div>
                        <div class="outlook-item">
                            <span class="outlook-label">If Untreated</span>
                            <span class="outlook-value critical">Fatal (AIDS)</span>
                        </div>
                        <div class="outlook-item">
                            <span class="outlook-label">With Treatment</span>
                            <span class="outlook-value positive">Normal lifespan</span>
                        </div>
                    </div>
                    <div class="sti-quick-facts">
                        <ul>
                            <li>üî¨ Low per-act transmission but serious consequences</li>
                            <li>üíä <span class="citable" data-source="hiv_viral_suppression">Undetectable = Untransmittable (U=U)<span class="cite-tooltip"><span class="cite-tooltip-source">CDC HIV Risk and Prevention Estimates</span><span class="cite-tooltip-quote">"no risk of sexual transmission. This translates to an effectiveness estimate of 100%"</span><a href="https://www.cdc.gov/hivpartners/php/riskandprevention/index.html#:~:text=no%20risk%20of%20sexual%20transmission.%20This%20translates%20to%20an%20effectiveness%20estimate%20of%20100%25" target="_blank" class="cite-tooltip-link">View Source ‚Üí</a></span></span></li>
                            <li>üõ°Ô∏è <span class="citable" data-source="hiv_condom_effectiveness">Condoms reduce risk by 80%<span class="cite-tooltip"><span class="cite-tooltip-source">CDC HIV Risk and Prevention Estimates</span><span class="cite-tooltip-quote">"Always using condoms, based on self-report, during sex with an HIV-positive partner reduces the risk of HIV acquisition by an estimated 80% among heterosexual men and women"</span><a href="https://www.cdc.gov/hivpartners/php/riskandprevention/index.html#:~:text=Always%20using%20condoms%2C%20based%20on%20self-report%2C%20during%20sex%20with%20an%20HIV-positive%20partner%20reduces%20the%20risk%20of%20HIV%20acquisition%20by%20an%20estimated%2080%25" target="_blank" class="cite-tooltip-link">View Source ‚Üí</a></span></span></li>
                            <li>üíâ <span class="citable" data-source="hiv_prep_effectiveness">PrEP reduces risk by ~99% when taken daily<span class="cite-tooltip"><span class="cite-tooltip-source">CDC HIV Risk and Prevention Estimates</span><span class="cite-tooltip-quote">"the risk of acquiring HIV is reduced by about 99% among MSM"</span><a href="https://www.cdc.gov/hivpartners/php/riskandprevention/index.html#:~:text=the%20risk%20of%20acquiring%20HIV%20is%20reduced%20by%20about%2099%25%20among%20MSM" target="_blank" class="cite-tooltip-link">View Source ‚Üí</a></span></span></li>
                            <li>‚ö†Ô∏è Higher risk with other STIs present (inflammation)</li>
                        </ul>
                    </div>
                    <div class="sti-rates">
                        <h4>Transmission Rates (per vaginal sex act)</h4>
                        <table class="rates-table">
                            <thead>
                                <tr>
                                    <th>Direction</th>
                                    <th>No Condom</th>
                                    <th>Condom Effectiveness</th>
                                </tr>
                            </thead>
                            <tbody>
                                <tr>
                                    <td>Male ‚Üí Female</td>
                                    <td><span class="citable" data-source="hiv_cdc_risk_estimates">0.08%<span class="cite-tooltip"><span class="cite-tooltip-source">CDC HIV Risk and Prevention Estimates</span><span class="cite-tooltip-quote">"Risk per 10,000 exposures ... Receptive penile-vaginal intercourse ... 8"</span><a href="https://www.cdc.gov/hivpartners/php/riskandprevention/index.html#:~:text=Risk%20per%2010%2C000%20exposures&text=Receptive%20penile-vaginal%20intercourse&text=Insertive%20penile-vaginal%20intercourse" target="_blank" class="cite-tooltip-link">View Source ‚Üí</a></span></span></td>
                                    <td rowspan="2"><span class="citable" data-source="hiv_condom_effectiveness">80% reduction<span class="cite-tooltip"><span class="cite-tooltip-source">CDC HIV Risk and Prevention Estimates</span><span class="cite-tooltip-quote">"Always using condoms, based on self-report, during sex with an HIV-positive partner reduces the risk of HIV acquisition by an estimated 80% among heterosexual men and women"</span><a href="https://www.cdc.gov/hivpartners/php/riskandprevention/index.html#:~:text=Always%20using%20condoms%2C%20based%20on%20self-report%2C%20during%20sex%20with%20an%20HIV-positive%20partner%20reduces%20the%20risk%20of%20HIV%20acquisition%20by%20an%20estimated%2080%25" target="_blank" class="cite-tooltip-link">View Source ‚Üí</a></span></span></td>
                                </tr>
                                <tr>
                                    <td>Female ‚Üí Male</td>
                                    <td><span class="citable" data-source="hiv_cdc_risk_estimates">0.04%<span class="cite-tooltip"><span class="cite-tooltip-source">CDC HIV Risk and Prevention Estimates</span><span class="cite-tooltip-quote">"Risk per 10,000 exposures ... Insertive penile-vaginal intercourse ... 4"</span><a href="https://www.cdc.gov/hivpartners/php/riskandprevention/index.html#:~:text=Risk%20per%2010%2C000%20exposures&text=Receptive%20penile-vaginal%20intercourse&text=Insertive%20penile-vaginal%20intercourse" target="_blank" class="cite-tooltip-link">View Source ‚Üí</a></span></span></td>
                                </tr>
                            </tbody>
                        </table>
                    </div>
                    <details class="sti-details">
                        <summary>Key Context</summary>
                        <div class="details-content">
                            <p>
                                HIV transmission probability varies significantly based on viral load, presence of other STIs, 
                                and stage of infection. The rates above assume a partner with detectable (untreated) HIV. 
                                Partners on effective antiretroviral therapy with undetectable viral load have essentially 
                                zero transmission risk (U=U: Undetectable = Untransmittable).
                            </p>
                            <p>
                                <strong>PrEP:</strong> Pre-exposure prophylaxis reduces risk by ~99% when taken daily.
                                <strong>PEP:</strong> Post-exposure prophylaxis can prevent infection if started within 72 hours.
                            </p>
                        </div>
                    </details>
                </article>

                <!-- HSV-2 -->
                <article class="sti-card" id="sti-hsv2">
                    <div class="sti-header">
                        <h3>Herpes (HSV-2)</h3>
                    </div>
                    <div class="sti-outlook">
                        <div class="outlook-item">
                            <span class="outlook-label">Duration</span>
                            <span class="outlook-value chronic">Chronic</span>
                        </div>
                        <div class="outlook-item">
                            <span class="outlook-label">If Untreated</span>
                            <span class="outlook-value low">Periodic outbreaks</span>
                        </div>
                        <div class="outlook-item">
                            <span class="outlook-label">With Treatment</span>
                            <span class="outlook-value positive">Rare/no outbreaks</span>
                        </div>
                    </div>
                    <div class="sti-quick-facts">
                        <ul>
                            <li>üîÑ Transmits via skin-to-skin contact, not just fluids</li>
                            <li>üò∂ <span class="citable" data-source="hsv2_cdc_asymptomatic">Most transmissions occur while asymptomatic<span class="cite-tooltip"><span class="cite-tooltip-source">CDC STD Treatment Guidelines</span><span class="cite-tooltip-quote">"most genital herpes infections are transmitted by persons unaware that they have the infection or who are asymptomatic when transmission occurs"</span><a href="https://www.cdc.gov/std/treatment-guidelines/herpes.htm#:~:text=most%20genital%20herpes%20infections%20are%20transmitted%20by%20persons%20unaware%20that%20they%20have%20the%20infection%20or%20who%20are%20asymptomatic%20when%20transmission%20occurs" target="_blank" class="cite-tooltip-link">View Source ‚Üí</a></span></span></li>
                            <li>üõ°Ô∏è <span class="citable" data-source="hsv2_magaret_2016">Condoms reduce risk by 96% M‚ÜíF, 65% F‚ÜíM<span class="cite-tooltip"><span class="cite-tooltip-source">Magaret et al. 2016 (Clin Infect Dis)</span><span class="cite-tooltip-quote">"condom use reduced per-act risk of transmission from men to women by 96% ... and marginally from women to men by 65%"</span><a href="https://pubmed.ncbi.nlm.nih.gov/26578538/#:~:text=condom%20use%20reduced%20per-act%20risk%20of%20transmission%20from%20men%20to%20women%20by%2096%25" target="_blank" class="cite-tooltip-link">View Source ‚Üí</a></span></span></li>
                            <li>üíä <span class="citable" data-source="hsv2_corey_2004">Daily antivirals (e.g., valacyclovir) reduce transmission by ~50%<span class="cite-tooltip"><span class="cite-tooltip-source">Corey et al. 2004 (NEJM)</span><span class="cite-tooltip-quote">"acquisition of HSV-2 was observed in 14 of the susceptible partners who received valacyclovir (1.9 percent), as compared with 27 (3.6 percent) who received placebo"</span><span class="cite-tooltip-math">Reduction: (3.6% - 1.9%) / 3.6% ‚âà 47-50%</span><a href="https://pubmed.ncbi.nlm.nih.gov/14702423/#:~:text=acquisition%20of%20HSV-2%20was%20observed%20in%2014%20of%20the%20susceptible%20partners%20who%20received%20valacyclovir%20(1.9%20percent)%2C%20as%20compared%20with%2027%20(3.6%20percent)%20who%20received%20placebo" target="_blank" class="cite-tooltip-link">View Source ‚Üí</a></span></span></li>
                            <li>üìÖ Avoiding sex during outbreaks significantly reduces risk</li>
                        </ul>
                    </div>
                    <div class="sti-rates">
                        <h4>Transmission Rates (per vaginal sex act)</h4>
                        <table class="rates-table">
                            <thead>
                                <tr>
                                    <th>Direction</th>
                                    <th>No Condom</th>
                                    <th>Condom Effectiveness</th>
                                </tr>
                            </thead>
                            <tbody>
                                <tr>
                                    <td>Male ‚Üí Female</td>
                                    <td><span class="citable" data-source="hsv2_per_act_derived">0.053%<span class="cite-tooltip"><span class="cite-tooltip-source">Corey et al. 2004 (NEJM) ‚Äî Derived</span><span class="cite-tooltip-quote">"The overall rate of transmission of HSV-2 was 3.6 per 100 person-years" ‚Äî Derived to per-act assuming ~70 acts over 8-month study period</span><a href="https://pubmed.ncbi.nlm.nih.gov/14702423/#:~:text=heterosexual%2C%20monogamous%20couples&text=eight%20months&text=3.6%20percent" target="_blank" class="cite-tooltip-link">View Source ‚Üí</a></span></span></td>
                                    <td><span class="citable" data-source="hsv2_condom_effectiveness">96% reduction<span class="cite-tooltip"><span class="cite-tooltip-source">Martin et al. 2009 (PMC) ‚Äî From Table 1</span><span class="cite-tooltip-quote">Table 1: "Use of condoms" ‚Üí Risk Ratio = 0.04 for susceptible women (1 - 0.04 = 96% reduction)</span><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC4725379/" target="_blank" class="cite-tooltip-link">View Source ‚Üí</a><span class="cite-tooltip-warning">‚ö†Ô∏è Data from table, not prose text</span></span></span></td>
                                </tr>
                                <tr>
                                    <td>Female ‚Üí Male</td>
                                    <td><span class="citable" data-source="hsv2_per_act_derived">0.053%<span class="cite-tooltip"><span class="cite-tooltip-source">Corey et al. 2004 (NEJM) ‚Äî Derived</span><span class="cite-tooltip-quote">"The overall rate of transmission of HSV-2 was 3.6 per 100 person-years" ‚Äî Derived to per-act (study didn't distinguish direction)</span><a href="https://pubmed.ncbi.nlm.nih.gov/14702423/#:~:text=heterosexual%2C%20monogamous%20couples&text=eight%20months&text=3.6%20percent" target="_blank" class="cite-tooltip-link">View Source ‚Üí</a></span></span></td>
                                    <td><span class="citable" data-source="hsv2_condom_effectiveness">65% reduction<span class="cite-tooltip"><span class="cite-tooltip-source">Martin et al. 2009 (PMC) ‚Äî From Table 1</span><span class="cite-tooltip-quote">Table 1: "Use of condoms" ‚Üí Risk Ratio = 0.35 for susceptible men (1 - 0.35 = 65% reduction)</span><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC4725379/" target="_blank" class="cite-tooltip-link">View Source ‚Üí</a><span class="cite-tooltip-warning">‚ö†Ô∏è Data from table; p=.060 (not statistically significant)</span></span></span></td>
                                </tr>
                            </tbody>
                        </table>
                        <p class="rate-note">
                            Note: Per-act rate derived from 8-month study. HSV-2 sheds asymptomatically, so transmission 
                            can occur without visible sores. Daily antivirals reduce transmission by ~50% on top of condoms.
                        </p>
                    </div>
                    <details class="sti-details">
                        <summary>Key Context</summary>
                        <div class="details-content">
                            <p>
                                HSV-2 transmission is complex because the virus sheds asymptomatically. Even without visible 
                                sores, transmission can occur. Avoiding sex during outbreaks significantly reduces risk.
                            </p>
                            <p>
                                <strong>Daily antivirals</strong> (e.g., valacyclovir) reduce transmission by ~50% on top of condom use.
                                Most people with HSV-2 are asymptomatic or have mild symptoms they don't recognize as herpes.
                            </p>
                            <div class="info-callout">
                                <h5>üí° What about HSV-1 (oral herpes)?</h5>
                                <p>
                                    HSV-1 typically causes cold sores and affects ~67% of people globally ‚Äî most acquired 
                                    non-sexually in childhood. However, HSV-1 <em>can</em> be transmitted to the genitals 
                                    through oral sex. Genital HSV-1 infections are increasingly common but tend to cause 
                                    fewer outbreaks than genital HSV-2.
                                </p>
                                <p>
                                    HSV-1 is not included in the risk calculator because: (1) most transmission is non-sexual, 
                                    and (2) oral-to-genital transmission rates are not well-quantified in the literature.
                                </p>
                            </div>
                        </div>
                    </details>
                </article>

                <!-- HPV -->
                <article class="sti-card" id="sti-hpv">
                    <div class="sti-header">
                        <h3>HPV (Human Papillomavirus)</h3>
                    </div>
                    <div class="sti-outlook">
                        <div class="outlook-item">
                            <span class="outlook-label">Duration</span>
                            <span class="outlook-value clears">Usually clears on its own</span>
                        </div>
                        <div class="outlook-item">
                            <span class="outlook-label">If Untreated</span>
                            <span class="outlook-value moderate">Some strains cause cancer</span>
                        </div>
                        <div class="outlook-item">
                            <span class="outlook-label">Prevention</span>
                            <span class="outlook-value positive">Vaccine highly effective</span>
                        </div>
                    </div>
                    <div class="sti-quick-facts">
                        <ul>
                            <li>üìä <span class="citable" data-source="hpv_lifetime_chesson">Most sexually active people get HPV at some point<span class="cite-tooltip"><span class="cite-tooltip-source">Chesson et al. 2014</span><span class="cite-tooltip-quote">"average lifetime probability of acquiring HPV among those with at least 1 opposite sex partner to be 84.6% ... for women and 91.3% ... for men"</span><a href="https://pubmed.ncbi.nlm.nih.gov/25299412/#:~:text=average%20lifetime%20probability%20of%20acquiring%20HPV%20among%20those%20with%20at%20least%201%20opposite%20sex%20partner%20to%20be%2084.6%25" target="_blank" class="cite-tooltip-link">View Source ‚Üí</a></span></span></li>
                            <li>üß¨ 200+ strains; most are harmless, some cause cancer</li>
                            <li>üõ°Ô∏è <span class="citable" data-source="hpv_condom_effectiveness">Condoms reduce risk by 70% with consistent use<span class="cite-tooltip"><span class="cite-tooltip-source">MDedge</span><span class="cite-tooltip-quote">"Women whose sexual partners consistently used condoms were 70% less likely to acquire genital human papillomavirus infection than were those whose partners did not"</span><a href="https://community.the-hospitalist.org/content/condoms-found-prevent-hpv-transmission#:~:text=Women%20whose%20sexual%20partners%20consistently%20used%20condoms%20were%2070%25%20less%20likely%20to%20acquire%20genital%20human%20papillomavirus%20infection%20than%20were%20those%20whose%20partners%20did%20not" target="_blank" class="cite-tooltip-link">View Source ‚Üí</a></span></span></li>
                            <li>üíâ Vaccine prevents the most dangerous strains</li>
                            <li>‚è≥ 90% of infections clear within 2 years</li>
                        </ul>
                    </div>
                    <div class="sti-rates">
                        <h4>Transmission Rates (per vaginal sex act)</h4>
                        <table class="rates-table">
                            <thead>
                                <tr>
                                    <th>Direction</th>
                                    <th>No Condom</th>
                                    <th>Condom Effectiveness</th>
                                </tr>
                            </thead>
                            <tbody>
                                <tr>
                                    <td>Male ‚Üí Female</td>
                                    <td><span class="citable" data-source="hpv_hitch_2021">0.41%<span class="cite-tooltip"><span class="cite-tooltip-source">Malag√≥n et al. 2021 (HITCH cohort) ‚Äî Derived</span><span class="cite-tooltip-quote">"The transmission rate from men to women was 3.5 ... per 100 person‚Äìmonths"</span><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC8012224/#:~:text=The%20transmission%20rate%20from%20men%20to%20women%20was%203.5&text=per%20100%20person%E2%80%93months" target="_blank" class="cite-tooltip-link">View Source ‚Üí</a></span></span></td>
                                    <td rowspan="2"><span class="citable" data-source="hpv_condom_effectiveness">70% reduction<span class="cite-tooltip"><span class="cite-tooltip-source">MDedge / Winer et al.</span><span class="cite-tooltip-quote">"Women whose sexual partners consistently used condoms were 70% less likely to acquire genital human papillomavirus infection"</span><a href="https://community.the-hospitalist.org/content/condoms-found-prevent-hpv-transmission#:~:text=Women%20whose%20sexual%20partners%20consistently%20used%20condoms%20were%2070%25%20less%20likely%20to%20acquire%20genital%20human%20papillomavirus%20infection" target="_blank" class="cite-tooltip-link">View Source ‚Üí</a></span></span></td>
                                </tr>
                                <tr>
                                    <td>Female ‚Üí Male</td>
                                    <td><span class="citable" data-source="hpv_hitch_2021">0.66%<span class="cite-tooltip"><span class="cite-tooltip-source">Malag√≥n et al. 2021 (HITCH cohort) ‚Äî Derived</span><span class="cite-tooltip-quote">"... from women to men was 5.6 (95%PI 3.8‚Äì7.0) per 100 person‚Äìmonths ... rate ratio of 1.6 (95%PI 1.0‚Äì2.5)"</span><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC8012224/#:~:text=from%20women%20to%20men%20was%205.6&text=per%20100%20person%E2%80%93months" target="_blank" class="cite-tooltip-link">View Source ‚Üí</a></span></span></td>
                                </tr>
                            </tbody>
                        </table>
                        <p class="rate-note">
                            Per-act rates derived from person-month data. HPV is highly variable ‚Äî most sexually active 
                            people get it at some point. Vaccine is the most effective prevention.
                        </p>
                    </div>
                    <details class="sti-details">
                        <summary>Key Context</summary>
                        <div class="details-content">
                            <p>
                                HPV is unique because it's so common that "preventing" it may be unrealistic for 
                                sexually active adults who aren't vaccinated. The medical establishment's approach 
                                has largely been to expect exposure and rely on the immune system to clear it.
                            </p>
                            <p>
                                <strong>The key questions:</strong> (1) Are you vaccinated? (2) Are you getting regular 
                                screenings (Pap smears for cervix-havers)? The vaccine prevents the strains that cause 
                                most cancers and genital warts.
                            </p>
                        </div>
                    </details>
                </article>

                <!-- Chlamydia -->
                <article class="sti-card" id="sti-chlamydia">
                    <div class="sti-header">
                        <h3>Chlamydia</h3>
                    </div>
                    <div class="sti-outlook">
                        <div class="outlook-item">
                            <span class="outlook-label">Duration</span>
                            <span class="outlook-value curable">Curable</span>
                        </div>
                        <div class="outlook-item">
                            <span class="outlook-label">If Untreated</span>
                            <span class="outlook-value moderate">PID, infertility risk</span>
                        </div>
                        <div class="outlook-item">
                            <span class="outlook-label">With Treatment</span>
                            <span class="outlook-value positive">Cured, no lasting effects</span>
                        </div>
                    </div>
                    <div class="sti-quick-facts">
                        <ul>
                            <li>ü¶† Most common bacterial STI</li>
                            <li>üò∂ <span class="citable" data-source="chlamydia_asymptomatic">~70% of women and 50% of men have no symptoms<span class="cite-tooltip"><span class="cite-tooltip-source">Finnish Student Health Service</span><span class="cite-tooltip-quote">"Chlamydia is often symptomless: about 50% of men and 70% of women have no symptoms"</span><a href="https://www.yths.fi/en/health-information-resource/chlamydia/#:~:text=Chlamydia%20is%20often%20symptomless%3A%20about%2050%25%20of%20men%20and%2070%25%20of%20women%20have%20no%20symptoms" target="_blank" class="cite-tooltip-link">View Source ‚Üí</a></span></span></li>
                            <li>üíä Easily cured with antibiotics (usually azithromycin)</li>
                            <li>üõ°Ô∏è <span class="citable" data-source="chlamydia_condom_effectiveness">Condoms reduce risk by 60%<span class="cite-tooltip"><span class="cite-tooltip-source">Crosby et al. 2004 (JAMA Pediatrics)</span><span class="cite-tooltip-quote">"We found that correct and consistent use of condoms reduced the risk of chlamydial infection by 60%"</span><a href="https://jamanetwork.com/journals/jamapediatrics/fullarticle/486033#:~:text=We%20found%20that%20correct%20and%20consistent%20use%20of%20condoms%20reduced%20the%20risk%20of%20chlamydial%20infection%20by%2060%25" target="_blank" class="cite-tooltip-link">View Source ‚Üí</a></span></span></li>
                            <li>‚ö†Ô∏è Untreated can cause PID, infertility</li>
                        </ul>
                    </div>
                    <div class="sti-rates">
                        <h4>Transmission Rates (per vaginal sex act)</h4>
                        <table class="rates-table">
                            <thead>
                                <tr>
                                    <th>Direction</th>
                                    <th>No Condom</th>
                                    <th>Condom Effectiveness</th>
                                </tr>
                            </thead>
                            <tbody>
                                <tr>
                                    <td>Male ‚Üí Female</td>
                                    <td><span class="citable" data-source="chlamydia_ncbi_per_act">11.4%<span class="cite-tooltip"><span class="cite-tooltip-source">NCBI Book NBK261441 ‚Äî Derived</span><span class="cite-tooltip-quote">"the per-sex act transmission probability for chlamydia ... is in the range 6‚Äì16.7%" ‚Äî Midpoint: 11.4%</span><a href="https://www.ncbi.nlm.nih.gov/books/NBK261441/#:~:text=the%20per-sex%20act%20transmission%20probability%20is%20uniformly%20distributed%20between%206%25%20and%2016.7%25" target="_blank" class="cite-tooltip-link">View Source ‚Üí</a></span></span></td>
                                    <td rowspan="2"><span class="citable" data-source="chlamydia_condom_effectiveness">60% reduction<span class="cite-tooltip"><span class="cite-tooltip-source">Crosby et al. 2004 (JAMA Pediatrics)</span><span class="cite-tooltip-quote">"We found that correct and consistent use of condoms reduced the risk of chlamydial infection by 60%"</span><a href="https://jamanetwork.com/journals/jamapediatrics/fullarticle/486033#:~:text=We%20found%20that%20correct%20and%20consistent%20use%20of%20condoms%20reduced%20the%20risk%20of%20chlamydial%20infection%20by%2060%25" target="_blank" class="cite-tooltip-link">View Source ‚Üí</a></span></span></td>
                                </tr>
                                <tr>
                                    <td>Female ‚Üí Male</td>
                                    <td><span class="citable" data-source="chlamydia_ncbi_per_act">11.4%<span class="cite-tooltip"><span class="cite-tooltip-source">NCBI Book NBK261441 ‚Äî Derived</span><span class="cite-tooltip-quote">"the per-sex act transmission probability for chlamydia ... is in the range 6‚Äì16.7%" ‚Äî Midpoint (no M‚ÜíF vs F‚ÜíM distinction in source)</span><a href="https://www.ncbi.nlm.nih.gov/books/NBK261441/#:~:text=the%20per-sex%20act%20transmission%20probability%20is%20uniformly%20distributed%20between%206%25%20and%2016.7%25" target="_blank" class="cite-tooltip-link">View Source ‚Üí</a></span></span></td>
                                </tr>
                            </tbody>
                        </table>
                        <p class="rate-note">
                            Per-act rate is midpoint of 6-17% range. Source does not distinguish M‚ÜíF vs F‚ÜíM.
                        </p>
                    </div>
                    <details class="sti-details">
                        <summary>Key Context</summary>
                        <div class="details-content">
                            <p>
                                Chlamydia is extremely common and often asymptomatic, which is why routine testing 
                                is recommended. It's easily treated but can cause serious complications if left untreated
                                (pelvic inflammatory disease, infertility).
                            </p>
                            <p>
                                <strong>Testing:</strong> Recommended annually for sexually active women under 25 and anyone 
                                with new or multiple partners. Treatment is simple: a single dose of azithromycin or a week of doxycycline.
                            </p>
                        </div>
                    </details>
                </article>

                <!-- Gonorrhea -->
                <article class="sti-card" id="sti-gonorrhea">
                    <div class="sti-header">
                        <h3>Gonorrhea</h3>
                    </div>
                    <div class="sti-outlook">
                        <div class="outlook-item">
                            <span class="outlook-label">Duration</span>
                            <span class="outlook-value curable">Curable</span>
                        </div>
                        <div class="outlook-item">
                            <span class="outlook-label">If Untreated</span>
                            <span class="outlook-value moderate">Spreads, infertility risk</span>
                        </div>
                        <div class="outlook-item">
                            <span class="outlook-label">With Treatment</span>
                            <span class="outlook-value positive">Cured, no lasting effects</span>
                        </div>
                    </div>
                    <div class="sti-quick-facts">
                        <ul>
                            <li>ü¶† Second most common bacterial STI</li>
                            <li>‚ö†Ô∏è <span class="citable" data-source="gonorrhea_resistance">Increasing antibiotic resistance is a global concern<span class="cite-tooltip"><span class="cite-tooltip-source">Kirkcaldy et al. 2019</span><span class="cite-tooltip-quote">"successively acquired antimicrobial resistance to each antimicrobial agent used and recommended for treatment ... The confluence of emerging resistance to cephalosporins and macrolides"</span><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC7064409/#:~:text=successively%20acquired%20antimicrobial%20resistance%20to%20each%20antimicrobial%20agent%20used%20and%20recommended%20for%20treatment" target="_blank" class="cite-tooltip-link">View Source ‚Üí</a></span></span></li>
                            <li>üíä Current treatment: ceftriaxone injection</li>
                            <li>üõ°Ô∏è <span class="citable" data-source="gonorrhea_condom_effectiveness">Condoms reduce risk by 90%<span class="cite-tooltip"><span class="cite-tooltip-source">Crosby et al. 2004 (JAMA Pediatrics)</span><span class="cite-tooltip-quote">"We found that correct and consistent use of condoms reduced the risk of gonorrhea by 90%"</span><a href="https://jamanetwork.com/journals/jamapediatrics/fullarticle/486033#:~:text=We%20found%20that%20correct%20and%20consistent%20use%20of%20condoms%20reduced%20the%20risk%20of%20gonorrhea%20by%2090%25" target="_blank" class="cite-tooltip-link">View Source ‚Üí</a></span></span></li>
                            <li>üî• More likely to cause symptoms than chlamydia (burning, discharge)</li>
                        </ul>
                    </div>
                    <div class="sti-rates">
                        <h4>Transmission Rates (per vaginal sex act)</h4>
                        <table class="rates-table">
                            <thead>
                                <tr>
                                    <th>Direction</th>
                                    <th>No Condom</th>
                                    <th>Condom Effectiveness</th>
                                </tr>
                            </thead>
                            <tbody>
                                <tr>
                                    <td>Male ‚Üí Female</td>
                                    <td><span class="citable" data-source="gonorrhea_ncbi_book">22.8%<span class="cite-tooltip"><span class="cite-tooltip-source">NCBI Book NBK261441 ‚Äî Derived</span><span class="cite-tooltip-quote">"the per-sex act transmission probability for gonorrhoea is assumed to be twice that of chlamydia" (chlamydia 6-16.7%, midpoint 11.4% √ó 2 = 22.8%)</span><a href="https://www.ncbi.nlm.nih.gov/books/NBK261441/#:~:text=the%20per-sex%20act%20transmission%20probability%20for%20gonorrhoea%20is%20assumed%20to%20be%20twice%20that%20of%20chlamydia" target="_blank" class="cite-tooltip-link">View Source ‚Üí</a></span></span></td>
                                    <td rowspan="2"><span class="citable" data-source="gonorrhea_condom_effectiveness">90% reduction<span class="cite-tooltip"><span class="cite-tooltip-source">Crosby et al. 2004 (JAMA Pediatrics)</span><span class="cite-tooltip-quote">"We found that correct and consistent use of condoms reduced the risk of gonorrhea by 90%"</span><a href="https://jamanetwork.com/journals/jamapediatrics/fullarticle/486033#:~:text=We%20found%20that%20correct%20and%20consistent%20use%20of%20condoms%20reduced%20the%20risk%20of%20gonorrhea%20by%2090%25" target="_blank" class="cite-tooltip-link">View Source ‚Üí</a></span></span></td>
                                </tr>
                                <tr>
                                    <td>Female ‚Üí Male</td>
                                    <td><span class="citable" data-source="gonorrhea_ncbi_book">22.8%<span class="cite-tooltip"><span class="cite-tooltip-source">NCBI Book NBK261441 ‚Äî Derived</span><span class="cite-tooltip-quote">"the per-sex act transmission probability for gonorrhoea is assumed to be twice that of chlamydia" ‚Äî Source does not distinguish M‚ÜíF vs F‚ÜíM</span><a href="https://www.ncbi.nlm.nih.gov/books/NBK261441/#:~:text=the%20per-sex%20act%20transmission%20probability%20for%20gonorrhoea%20is%20assumed%20to%20be%20twice%20that%20of%20chlamydia" target="_blank" class="cite-tooltip-link">View Source ‚Üí</a></span></span></td>
                                </tr>
                            </tbody>
                        </table>
                        <p class="rate-note">
                            Per-act rate derived from 2√ó chlamydia. Source does not distinguish M‚ÜíF vs F‚ÜíM.
                        </p>
                    </div>
                    <details class="sti-details">
                        <summary>Key Context</summary>
                        <div class="details-content">
                            <p>
                                Gonorrhea is highly infectious ‚Äî even a single unprotected encounter carries significant risk.
                                Unlike chlamydia, gonorrhea often causes noticeable symptoms (burning, discharge).
                            </p>
                            <p>
                                <strong>Antibiotic resistance</strong> is a growing concern. Current treatment requires a 
                                ceftriaxone injection. If you've had gonorrhea, get retested 3 months after treatment to 
                                ensure it's cleared and you haven't been reinfected.
                            </p>
                        </div>
                    </details>
                </article>

                <!-- Syphilis -->
                <article class="sti-card" id="sti-syphilis">
                    <div class="sti-header">
                        <h3>Syphilis</h3>
                    </div>
                    <div class="sti-outlook">
                        <div class="outlook-item">
                            <span class="outlook-label">Duration</span>
                            <span class="outlook-value curable">Curable</span>
                        </div>
                        <div class="outlook-item">
                            <span class="outlook-label">If Untreated</span>
                            <span class="outlook-value serious">Organ damage, death</span>
                        </div>
                        <div class="outlook-item">
                            <span class="outlook-label">With Treatment</span>
                            <span class="outlook-value positive">Cured, no lasting effects</span>
                        </div>
                    </div>
                    <div class="sti-quick-facts">
                        <ul>
                            <li>üìà Cases are surging after decades of decline</li>
                            <li>üî¥ Primary stage: painless sore (chancre)</li>
                            <li>üíä Easily cured with penicillin</li>
                            <li>üõ°Ô∏è <span class="citable" data-source="syphilis_condom_effectiveness">Condoms reduce risk by 50-71%<span class="cite-tooltip"><span class="cite-tooltip-source">PMC Condom Review</span><span class="cite-tooltip-quote">"syphilis transmission is reduced 29% for typical use ... It is reduced 50-71% when condoms are used 100% of the time correctly"</span><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC4660551/#:~:text=syphilis%20transmission%20is%20reduced%2029%25%20for%20typical%20use&text=It%20is%20reduced%2050-71%25%20when%20condoms%20are%20used%20100%25%20of%20the%20time%20correctly" target="_blank" class="cite-tooltip-link">View Source ‚Üí</a></span></span> (sores may be outside covered area)</li>
                            <li>‚ö†Ô∏è Untreated can cause serious organ damage years later</li>
                        </ul>
                    </div>
                    <div class="sti-rates">
                        <h4>Transmission Rates (per vaginal sex act)</h4>
                        <table class="rates-table">
                            <thead>
                                <tr>
                                    <th>Stage</th>
                                    <th>No Condom</th>
                                    <th>Condom Effectiveness</th>
                                </tr>
                            </thead>
                            <tbody>
                                <tr>
                                    <td>Early syphilis (primary, secondary, early latent)</td>
                                    <td><span class="citable" data-source="syphilis_ashm_per_act">&gt;20%<span class="cite-tooltip"><span class="cite-tooltip-source">ASHM Contact Tracing Guidelines</span><span class="cite-tooltip-quote">"The overall probability of transmission of syphilis during early infection is estimated to be greater than 20% per contact"</span><a href="https://contacttracing.ashm.org.au/syphilis/#:~:text=The%20overall%20probability%20of%20transmission%20of%20syphilis%20during%20early%20infection%20is%20estimated%20to%20be%20greater%20than%2020%25%20per%20contact" target="_blank" class="cite-tooltip-link">View Source ‚Üí</a></span></span></td>
                                    <td rowspan="2"><span class="citable" data-source="syphilis_condom_effectiveness">50-71% reduction<span class="cite-tooltip"><span class="cite-tooltip-source">PMC4660551 ‚Äî Condom Review</span><span class="cite-tooltip-quote">"Syphilis transmission is reduced 29% for typical use. It is reduced 50‚Äì71% when condoms are used 100% of the time correctly."</span><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC4660551/#:~:text=Syphilis%20transmission%20is%20reduced%2029%25%20for%20typical%20use.%20It%20is%20reduced%2050%E2%80%9371%25%20when%20condoms%20are%20used%20100%25%20of%20the%20time%20correctly" target="_blank" class="cite-tooltip-link">View Source ‚Üí</a></span></span></td>
                                </tr>
                                <tr>
                                    <td>Latent stage</td>
                                    <td><span class="citable-unverified">Low<span class="unverified-tooltip">‚ö†Ô∏è Needs verification ‚Äî not well quantified in literature</span></span></td>
                                </tr>
                            </tbody>
                        </table>
                        <p class="rate-note">
                            Transmission depends heavily on stage. Primary/secondary stages are highly infectious. 
                            Condoms less effective than for other STIs because sores may be outside covered area.
                        </p>
                    </div>
                    <details class="sti-details">
                        <summary>Key Context</summary>
                        <div class="details-content">
                            <p>
                                Syphilis progresses through stages, and transmission risk varies dramatically. 
                                The primary chancre (sore) is the most infectious period. If you can see a sore, 
                                avoid contact ‚Äî that's when transmission is most likely.
                            </p>
                            <p>
                                <strong>Syphilis is resurging</strong> after decades of decline. Get tested if sexually active, 
                                especially with new partners. Treatment is simple: a penicillin injection cures it at any stage, 
                                though damage from late-stage syphilis cannot be reversed.
                            </p>
                        </div>
                    </details>
                </article>

                <!-- Hepatitis B -->
                <article class="sti-card" id="sti-hepb">
                    <div class="sti-header">
                        <h3>Hepatitis B</h3>
                    </div>
                    <div class="sti-outlook">
                        <div class="outlook-item">
                            <span class="outlook-label">Duration</span>
                            <span class="outlook-value clears">Usually clears (~95% of adults recover)</span>
                        </div>
                        <div class="outlook-item">
                            <span class="outlook-label">If Untreated</span>
                            <span class="outlook-value serious">Liver cancer, cirrhosis, death</span>
                        </div>
                        <div class="outlook-item">
                            <span class="outlook-label">Prevention</span>
                            <span class="outlook-value positive">Vaccine is highly effective</span>
                        </div>
                    </div>
                    <div class="sti-quick-facts">
                        <ul>
                            <li>üíâ <strong>Vaccine-preventable</strong> ‚Äî most effective prevention method</li>
                            <li>‚ö†Ô∏è More infectious sexually than HIV (per-partnership rates 25-44%)</li>
                            <li>üõ°Ô∏è <span class="citable" data-source="hepb_condom_effectiveness">Condoms provide >90% protection<span class="cite-tooltip"><span class="cite-tooltip-source">PMC Condom Review</span><span class="cite-tooltip-quote">"The condom offers maximum protection (more than 90%) against HIV, Hepatitis B virus and N.Gonorrhoea"</span><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC4660551/#:~:text=The%20condom%20offers%20maximum%20protection%20(more%20than%2090%25)%20against%20HIV%2C%20Hepatitis%20B%20virus%20and%20N.Gonorrhoea" target="_blank" class="cite-tooltip-link">View Source ‚Üí</a></span></span></li>
                            <li>üìä <span class="citable" data-source="hepb_chronic_by_age">~95% of infected adults recover completely (only ~5% become chronic)<span class="cite-tooltip"><span class="cite-tooltip-source">CDC Hepatitis B Clinical Overview</span><span class="cite-tooltip-quote">"90% of infected infants ... will remain chronically infected with HBV. By contrast, approximately 95% of infected adults recover completely"</span><a href="https://www.cdc.gov/hepatitis-b/hcp/clinical-overview/index.html#:~:text=90%25%20of%20infected%20infants&text=95%25%20of%20infected%20adults%20recover%20completely" target="_blank" class="cite-tooltip-link">View Source ‚Üí</a></span></span></li>
                            <li>‚ö†Ô∏è Infants: 90% become chronic ‚Äî vaccination at birth is critical</li>
                        </ul>
                    </div>
                    <div class="sti-rates">
                        <h4>Transmission Rates</h4>
                        <div class="rates-table">
                            <div class="rate-section">
                                <h5 class="rate-section-title">Without Condom</h5>
                                <div class="rate-item">
                                    <span class="rate-label">Per partnership</span>
                                    <span class="rate-value">
                                        <span class="citable-unverified" title="Per-act rate varies widely">25‚Äì44%<span class="cite-tooltip"><span class="cite-tooltip-source">Multiple Sources</span><span class="cite-tooltip-quote">Per-partnership transmission rates range from 18-44% depending on viral load. Per-act rates vary widely based on HBeAg status.</span><span class="cite-tooltip-warning">‚ö†Ô∏è Per-act rate not reliably quantified. Risk is MUCH higher if partner has high viral load (HBeAg positive).</span></span></span>
                                    </span>
                                </div>
                            </div>
                            <div class="rate-section">
                                <h5 class="rate-section-title">With Condom</h5>
                                <div class="rate-item">
                                    <span class="rate-label">Reduction</span>
                                    <span class="rate-value">
                                        <span class="citable" data-source="hepb_condom_effectiveness">>90%<span class="cite-tooltip"><span class="cite-tooltip-source">PMC Condom Review</span><span class="cite-tooltip-quote">"The condom offers maximum protection (more than 90%) against HIV, Hepatitis B virus and N.Gonorrhoea"</span><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC4660551/#:~:text=The%20condom%20offers%20maximum%20protection%20(more%20than%2090%25)%20against%20HIV%2C%20Hepatitis%20B%20virus%20and%20N.Gonorrhoea" target="_blank" class="cite-tooltip-link">View Source ‚Üí</a></span></span>
                                    </span>
                                </div>
                            </div>
                        </div>
                    </div>
                    <details class="sti-details">
                        <summary>View Full Details</summary>
                        <div class="sti-details-content">
                            <h4>Key Context</h4>
                            <p>
                                <strong>Hepatitis B is NOT Hepatitis C.</strong> People confuse these constantly. 
                                Hep B is sexually transmitted and quite infectious. Hep C is primarily blood-borne and 
                                almost never transmitted through heterosexual vaginal sex (~1 in 190,000 per contact).
                            </p>
                            <p>
                                <strong>Vaccination is key.</strong> The Hep B vaccine is extremely effective and is now 
                                routinely given to infants. If you weren't vaccinated as a child, you should get vaccinated 
                                ‚Äî especially before new sexual partners.
                            </p>
                            <p>
                                <strong>Why no calculator?</strong> Per-act transmission rates vary enormously based on 
                                the infected partner's viral load (HBeAg status). Someone with active viral replication 
                                is far more infectious. This makes a simple calculator misleading.
                            </p>
                        </div>
                    </details>
                </article>

                <!-- Trichomoniasis -->
                <article class="sti-card" id="sti-trichomoniasis">
                    <div class="sti-header">
                        <h3>Trichomoniasis</h3>
                    </div>
                    <div class="sti-outlook">
                        <div class="outlook-item">
                            <span class="outlook-label">Duration</span>
                            <span class="outlook-value curable">Curable</span>
                        </div>
                        <div class="outlook-item">
                            <span class="outlook-label">If Untreated</span>
                            <span class="outlook-value moderate">Pregnancy complications, HIV risk</span>
                        </div>
                        <div class="outlook-item">
                            <span class="outlook-label">With Treatment</span>
                            <span class="outlook-value positive">Cured with single dose</span>
                        </div>
                    </div>
                    <div class="sti-quick-facts">
                        <ul>
                            <li>ü•á <span class="citable" data-source="trich_cdc_prevalence">Most common curable STI (~2.6 million US cases)<span class="cite-tooltip"><span class="cite-tooltip-source">CDC STI Treatment Guidelines</span><span class="cite-tooltip-quote">"Trichomoniasis is estimated to be the most prevalent nonviral STI worldwide, affecting approximately 2.6 million persons in the United States"</span><a href="https://www.cdc.gov/std/treatment-guidelines/trichomoniasis.htm#:~:text=Trichomoniasis%20is%20estimated%20to%20be%20the%20most%20prevalent%20nonviral%20STI%20worldwide%2C%20affecting%20approximately%202.6%20million%20persons%20in%20the%20United%20States" target="_blank" class="cite-tooltip-link">View Source ‚Üí</a></span></span></li>
                            <li>üò∂ <span class="citable" data-source="trich_cdc_asymptomatic">70-85% have no symptoms<span class="cite-tooltip"><span class="cite-tooltip-source">CDC STI Treatment Guidelines</span><span class="cite-tooltip-quote">"The majority of persons who have trichomoniasis (70%‚Äì85%) either have minimal or no genital symptoms, and untreated infections might last from months to years"</span><a href="https://www.cdc.gov/std/treatment-guidelines/trichomoniasis.htm#:~:text=The%20majority%20of%20persons%20who%20have%20trichomoniasis%20(70%25%E2%80%9385%25)%20either%20have%20minimal%20or%20no%20genital%20symptoms" target="_blank" class="cite-tooltip-link">View Source ‚Üí</a></span></span></li>
                            <li>üíä Easily cured with one dose of metronidazole or tinidazole</li>
                            <li>üõ°Ô∏è <span class="citable" data-source="trich_condom_effectiveness">Condom effectiveness controversial (~30% reduction observed)<span class="cite-tooltip"><span class="cite-tooltip-source">PMC Condom Review</span><span class="cite-tooltip-quote">"It is claimed to provide more than 90% protection against Trichomonas vaginitis, but the latest reports are controversial. Statistically significant reduction in trichomonas infection (30%) was reported with condom use."</span><span class="cite-tooltip-warning">‚ö†Ô∏è Earlier claims of >90% protection are disputed. More recent studies show only ~30% reduction.</span><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC4660551/#:~:text=It%20is%20claimed%20to%20provide%20more%20than%2090%25%20protection%20against%20Trichomonas%20vaginitis%2C%20but%20the%20latest%20reports%20are%20controversial.%20Statistically%20significant%20reduction%20in%20trichomonas%20infection%20(30%25)%20was%20reported%20with%20condom%20use" target="_blank" class="cite-tooltip-link">View Source ‚Üí</a></span></span></li>
                            <li>üåç <span class="citable" data-source="trich_who_global">156 million new cases globally per year<span class="cite-tooltip"><span class="cite-tooltip-source">WHO Fact Sheet</span><span class="cite-tooltip-quote">"In 2020 there were approximately 156 million new cases of T. vaginalis infection among people aged 15‚Äì49 years old"</span><a href="https://www.who.int/news-room/fact-sheets/detail/trichomoniasis#:~:text=In%202020%20there%20were%20approximately%20156%20million%20new%20cases%20of%20T.%20vaginalis%20infection%20among%20people%20aged%2015%E2%80%9349%20years%20old" target="_blank" class="cite-tooltip-link">View Source ‚Üí</a></span></span></li>
                            <li>‚ö†Ô∏è <span class="citable" data-source="trich_hiv_risk">Increases HIV acquisition risk by ~1.5x<span class="cite-tooltip"><span class="cite-tooltip-source">CDC STI Treatment Guidelines</span><span class="cite-tooltip-quote">"T. vaginalis infection is associated with a 1.5-fold increased risk for HIV acquisition and is associated with an increase in HIV vaginal shedding"</span><a href="https://www.cdc.gov/std/treatment-guidelines/trichomoniasis.htm#:~:text=T.%20vaginalis%20infection%20is%20associated%20with%20a%201.5-fold%20increased%20risk%20for%20HIV%20acquisition%20and%20is%20associated%20with%20an%20increase%20in%20HIV%20vaginal%20shedding" target="_blank" class="cite-tooltip-link">View Source ‚Üí</a></span></span></li>
                        </ul>
                    </div>
                    <div class="sti-rates">
                        <h4>Transmission Rates</h4>
                        <div class="rates-table">
                            <div class="rate-section">
                                <h5 class="rate-section-title">Without Condom</h5>
                                <div class="rate-item">
                                    <span class="rate-label">Vaginal sex</span>
                                    <span class="rate-value">
                                        <span class="citable-unverified" title="Per-act rate unknown">Unknown<span class="cite-tooltip"><span class="cite-tooltip-source">ASHM Contact Tracing Guidelines</span><span class="cite-tooltip-quote">"Likelihood of transmission per act of unprotected intercourse ... Unknown, likely moderate to high"</span><span class="cite-tooltip-warning">‚ö†Ô∏è No quantified per-act rate exists in medical literature. Cannot be used in risk calculator.</span><a href="https://contacttracing.ashm.org.au/trichomoniasis/#:~:text=Likelihood%20of%20transmission%20per%20act%20of%20unprotected%20intercourse&text=Unknown%2C%20likely%20moderate%20to%20high" target="_blank" class="cite-tooltip-link">View Source ‚Üí</a></span></span>
                                    </span>
                                </div>
                            </div>
                            <div class="rate-section">
                                <h5 class="rate-section-title">With Condom</h5>
                                <div class="rate-item">
                                    <span class="rate-label">Reduction</span>
                                    <span class="rate-value">
                                        <span class="citable" data-source="trich_condom_effectiveness">30‚Äì90% reduction (disputed)<span class="cite-tooltip"><span class="cite-tooltip-source">PMC Condom Review</span><span class="cite-tooltip-quote">"It is claimed to provide more than 90% protection against Trichomonas vaginitis, but the latest reports are controversial. Statistically significant reduction in trichomonas infection (30%) was reported with condom use."</span><span class="cite-tooltip-warning">‚ö†Ô∏è Condom effectiveness for trichomoniasis is controversial. Earlier claims of >90% are disputed by newer studies showing ~30%.</span><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC4660551/#:~:text=It%20is%20claimed%20to%20provide%20more%20than%2090%25%20protection%20against%20Trichomonas%20vaginitis%2C%20but%20the%20latest%20reports%20are%20controversial.%20Statistically%20significant%20reduction%20in%20trichomonas%20infection%20(30%25)%20was%20reported%20with%20condom%20use" target="_blank" class="cite-tooltip-link">View Source ‚Üí</a></span></span>
                                    </span>
                                </div>
                            </div>
                        </div>
                    </div>
                    <details class="sti-details">
                        <summary>View Full Details</summary>
                        <div class="sti-details-content">
                            <h4>Key Context</h4>
                            <p>
                                Trichomoniasis is often called the "neglected STI" ‚Äî it's the most common curable sexually transmitted infection, 
                                yet it receives far less attention than chlamydia or gonorrhea. Unlike those, it's not nationally reportable in the U.S.
                            </p>
                            <p>
                                <strong>Why can't we calculate risk?</strong> Despite being extremely common, there are no published per-act 
                                transmission rates for trichomoniasis. Medical literature describes it as "moderate to high" but provides no 
                                specific numbers. This is a gap in sexual health research.
                            </p>
                            <p>
                                <strong>Testing:</strong> Trichomoniasis is often NOT included in standard STI panels. You may need to specifically 
                                request testing. Diagnosis is via NAAT (urine or swab). Treatment is simple: a single oral dose of metronidazole 
                                or tinidazole cures ~95% of cases.
                            </p>
                        </div>
                    </details>
                </article>
            </div>
        </div>
    </section>

    <section id="methodology" class="section methodology-section">
        <div class="container">
            <div class="section-header">
                <span class="section-tag">Transparency</span>
                <h2>Methodology</h2>
                <p class="section-desc">
                    How we calculate transmission probabilities and where the numbers come from.
                </p>
            </div>
            
            <div class="methodology-content">
                <div class="method-block">
                    <h3>The Core Equation</h3>
                    <p>
                        All risk calculations use the same fundamental probability formula. 
                        If each exposure has independent risk \( r \), then after \( n \) exposures:
                    </p>
                    <div class="math-block large">
                        <p>\[ P_{transmission} = 1 - (1 - r)^n \]</p>
                    </div>
                    <p>Intuitively: we calculate the probability of <em>not</em> getting infected after each encounter, 
                    multiply them together, then subtract from 1.</p>
                    
                    <div class="code-block">
                        <h4>JavaScript Implementation</h4>
<pre><code>function calculateCumulativeRisk(perActRisk, numberOfEncounters) {
    // Probability of NOT being infected after all encounters
    const probNotInfected = Math.pow(1 - perActRisk, numberOfEncounters);
    
    // Probability of being infected = 1 - (prob of not infected)
    return 1 - probNotInfected;
}

// Example: Chlamydia (12.5% per act), 8 encounters
calculateCumulativeRisk(0.125, 8);  // Returns: 0.656 (65.6%)</code></pre>
                    </div>
                </div>
                
                <div class="method-block">
                    <h3>Adjusting for Condom Use</h3>
                    <p>
                        Condoms reduce transmission by a certain percentage, depending on the STI. 
                        We multiply the base risk by (1 - effectiveness):
                    </p>
                    <div class="math-block">
                        <p>\[ r_{protected} = r_{unprotected} \times (1 - e_{condom}) \]</p>
                    </div>
                    <div class="code-block">
<pre><code>function adjustForCondom(baseRisk, condomEffectiveness) {
    return baseRisk * (1 - condomEffectiveness);
}

// HIV: 0.08% base, 80% condom effectiveness
adjustForCondom(0.0008, 0.80);  // Returns: 0.00016 (0.016%)</code></pre>
                    </div>
                </div>

                <div class="method-block">
                    <h3>Limitations & Caveats</h3>
                    <div class="caveats-grid">
                        <div class="caveat">
                            <h4>üéØ Individual Variation</h4>
                            <p>Risk varies by viral load, inflammation, other infections, and biological factors. 
                            Population averages may not reflect your specific risk.</p>
                        </div>
                        <div class="caveat">
                            <h4>üìä Study Populations</h4>
                            <p>Studies often focus on specific populations (e.g., discordant couples, clinic attendees). 
                            Results may not generalize to all scenarios.</p>
                        </div>
                        <div class="caveat">
                            <h4>üîÑ Independence Assumption</h4>
                            <p>The formula assumes each encounter is independent. In reality, factors like 
                            mucosal trauma or co-infections can create dependencies.</p>
                        </div>
                        <div class="caveat">
                            <h4>üìÖ Data Age</h4>
                            <p>Some studies are older. HIV treatment has improved dramatically; resistance patterns 
                            change. We cite dates so you can assess currency.</p>
                        </div>
                    </div>
                </div>
            </div>
        </div>
    </section>

    <footer class="footer">
        <div class="container">
            <div class="footer-content">
                <div class="footer-main">
                    <h3>Know Your Numbers</h3>
                    <p>Transparent, data-driven sexual health information.</p>
                    <p class="footer-disclaimer">
                        This website provides educational information only and is not medical advice. 
                        Consult a healthcare provider for personal medical decisions.
                    </p>
                </div>
                <div class="footer-links">
                    <h4>Resources</h4>
                    <ul>
                        <li><a href="https://www.cdc.gov/sti/" target="_blank">CDC STI Homepage</a></li>
                        <li><a href="https://www.plannedparenthood.org/" target="_blank">Planned Parenthood</a></li>
                        <li><a href="https://www.cdc.gov/sti/testing/index.html" target="_blank">Find Testing Near You</a></li>
                    </ul>
                </div>
                <div class="footer-links">
                    <h4>On This Site</h4>
                    <ul>
                        <li><a href="#mission">Why This Exists</a></li>
                        <li><a href="#calculator">Risk Calculator</a></li>
                        <li><a href="#methodology">Methodology</a></li>
                    </ul>
                </div>
            </div>
            <div class="footer-bottom">
                <p>Made with frustration and math. Open source on GitHub.</p>
            </div>
        </div>
    </footer>

    <script src="app.js"></script>
</body>
</html>
